Literature DB >> 20161093

A Class of Transformed Mean Residual Life Models With Censored Survival Data.

Liuquan Sun1, Zhigang Zhang.   

Abstract

The mean residual life function is an attractive alternative to the survival function or the hazard function of a survival time in practice. It provides the remaining life expectancy of a subject surviving up to time t. In this study, we propose a class of transformed mean residual life models for fitting survival data under right censoring. To estimate the model parameters, we make use of the inverse probability of censoring weighting approach and develop a system of estimating equations. Efficiency and robustness of the estimators are also studied. Both asymptotic and finite sample properties of the proposed estimators are established and the approach is applied to two real-life datasets collected from clinical trials.

Entities:  

Year:  2009        PMID: 20161093      PMCID: PMC2744430          DOI: 10.1198/jasa.2009.0130

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  7 in total

1.  Efficient estimation of the distribution of quality-adjusted survival time.

Authors:  H Zhao; A A Tsiatis
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Median regression with censored cost data.

Authors:  Heejung Bang; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

3.  Semiparametric estimation of proportional mean residual life model in presence of censoring.

Authors:  Y Q Chen; N P Jewell; X Lei; S C Cheng
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  A doubly robust censoring unbiased transformation.

Authors:  Daniel Rubin; Mark J van der Laan
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

5.  Toward a curse of dimensionality appropriate (CODA) asymptotic theory for semi-parametric models.

Authors:  J M Robins; Y Ritov
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

6.  Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes.

Authors:  Michael J Zelefsky; Yoshiya Yamada; Zvi Fuks; Zhigang Zhang; Margie Hunt; Oren Cahlon; Jessica Park; Alison Shippy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-14       Impact factor: 7.038

7.  The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.

Authors: 
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

  7 in total
  5 in total

1.  Backward multiple imputation estimation of the conditional lifetime expectancy function with application to censored human longevity data.

Authors:  Jing Kong; Barbara E K Klein; Ronald Klein; Grace Wahba
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

2.  Generalized mean residual life models for case-cohort and nested case-control studies.

Authors:  Peng Jin; Anne Zeleniuch-Jacquotte; Mengling Liu
Journal:  Lifetime Data Anal       Date:  2020-06-11       Impact factor: 1.588

3.  Goodness-of-fit tests for additive mean residual life model under right censoring.

Authors:  Zhigang Zhang; Xingqiu Zhao; Liuquan Sun
Journal:  Lifetime Data Anal       Date:  2010-01-26       Impact factor: 1.588

4.  Nonparametric estimation of the conditional mean residual life function with censored data.

Authors:  Alexander C McLain; Sujit K Ghosh
Journal:  Lifetime Data Anal       Date:  2011-05-21       Impact factor: 1.588

5.  A proposal for an additional clinical trial outcome measure assessing preventive effect as delay of events.

Authors:  Per Lytsy; Lars Berglund; Johan Sundström
Journal:  Eur J Epidemiol       Date:  2012-12-07       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.